NASDAQ:MDXH

Mdxhealth Sa Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy MDXH

*Your capital is at risk

$0.603

-0.0378 (-5.90%)

At Close: Jun 03, 2026

MDxHealth SA Stock Insider Power

Based on the 30 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 3.64M and sold 0 MDXH shares in the last 30 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 30 transactions)	100.00
● Buy	3.64M shares
● Sell	0 shares
100% Buy Activity Weak Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 18, 2026 Buy	Common Stock J-Other	Oconnell Brendan Insider	Other	0 Value: $0
Mar 18, 2026 Buy	Ordinary Shares	Bednarski Eric Director	Director	0 Value: $0
Mar 18, 2026 Buy	Share Option	Bellano John Chief Commercial Officer	Officer	20 000 Value: $65.4K
Mar 18, 2026 Buy	Share Option	Bellano John Chief Commercial Officer	Officer	65 000 Value: $170.3K
Mar 18, 2026 Buy	Share Option	Bellano John Chief Commercial Officer	Officer	200 000 Value: $294.0K
Mar 18, 2026 Buy	Ordinary Shares	Mcgarrity Michael Chief Executive Officer	CEO / President	0 Value: $0
Mar 18, 2026 Buy	Share Option	Mcgarrity Michael Chief Executive Officer	CEO / President	50 000 Value: $163.5K
Mar 18, 2026 Buy	Share Option	Mcgarrity Michael Chief Executive Officer	CEO / President	186 875 Value: $489.6K
Mar 18, 2026 Buy	Share Option	Mcgarrity Michael Chief Executive Officer	CEO / President	500 000 Value: $735.0K
Mar 18, 2026 Buy	Share Option	Sollee Joseph See Remarks	Officer	20 000 Value: $65.4K
Mar 18, 2026 Buy	Share Option	Sollee Joseph See Remarks	Officer	65 000 Value: $170.3K
Mar 18, 2026 Buy	Share Option	Sollee Joseph See Remarks	Officer	200 000 Value: $294.0K
Mar 18, 2026 Buy	Share Option	Kalfus Ron Chief Financial Officer	C-Suite Officer	12 000 Value: $39.2K
Mar 18, 2026 Buy	Share Option	Kalfus Ron Chief Financial Officer	C-Suite Officer	75 000 Value: $196.5K
Mar 18, 2026 Buy	Share Option	Kalfus Ron Chief Financial Officer	C-Suite Officer	100 000 Value: $147.0K
Mar 18, 2026 Buy	Share Option	Hardison Don M Director	Director	30 000 Value: $78.6K
Mar 18, 2026 Buy	Share Option	Hardison Don M Director	Director	10 000 Value: $21.8K
Mar 18, 2026 Buy	Share Option	Siegel Sanford Jay Director	Director	10 000 Value: $21.8K
Mar 18, 2026 Buy	Share Option	Windels Hilde Director	Director	1 000 Value: $3K
Mar 18, 2026 Buy	Share Option	Windels Hilde Director	Director	30 000 Value: $78.6K
Mar 18, 2026 Buy	Share Option	Windels Hilde Director	Director	10 000 Value: $21.8K
Mar 18, 2026 Buy	Share Option	Hoffman Koen Director	Director	2 000 Value: $7K
Mar 18, 2026 Buy	Share Option	Hoffman Koen Director	Director	30 000 Value: $78.6K
Mar 18, 2026 Buy	Share Option	Hoffman Koen Director	Director	10 000 Value: $21.8K
Mar 18, 2026 Buy	Ordinary Shares	Mvm Partners, Llc Director	Director	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MDXHEALTH SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use ...

Read Full Profile Here